Listed

Adaptimmune Therapeutics PLC

ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31

Reports and events: 279 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Adaptimmune Therapeutics PLC, Reports and events
FiledFormWhat it isAccession number
2021-05-1917:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-21-007554
2021-05-1408:39 ET8-K5.07 Shareholder vote results0001104659-21-066437
2021-05-0616:16 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-006230
2021-05-0607:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-006075
2021-04-0808:00 ETDEF 14AProxy statementPeriod 2021-05-140001104659-21-047833
2021-02-2516:18 ET10-KAnnual reportPeriod 2020-12-310001558370-21-001827
2021-02-2507:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001558370-21-001720
2020-12-1617:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-20-136370
2020-11-2007:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-20-014003
2020-11-1909:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001558370-20-013984
2020-11-0917:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-123143
2020-11-0516:18 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-012867
2020-11-0507:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-121583
2020-10-1516:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-115322
2020-08-2810:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-099887
2020-08-0611:17 ET10-QQuarterly reportPeriod 2020-06-300001558370-20-009555
2020-08-0607:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-091131
2020-06-0216:49 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-069003
2020-05-2907:42 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-067350
2020-05-2907:07 ET8-K5.07 Shareholder vote results0001104659-20-067340
2020-05-2816:37 ET10-Q/AQuarterly report, amendedPeriod 2020-03-310001104659-20-067101
2020-05-1411:02 ET10-QQuarterly reportPeriod 2020-03-310001558370-20-006569
2020-05-1407:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-061166
2020-05-1210:54 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-059925
2020-04-2908:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-052846
2020-04-2808:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-051986
2020-04-2008:00 ETDEF 14AProxy statementPeriod 2020-05-290001104659-20-048476
2020-04-0808:06 ET8-K5.02 Departure or appointment of officers or directors0001104659-20-044489
2020-02-2711:50 ET10-KAnnual reportPeriod 2019-12-310001558370-20-001571
2020-02-2707:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-025722
2020-02-1808:07 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-022267
2020-02-0716:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-012543
2020-01-2217:30 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-005985
2020-01-1406:17 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-003597
2020-01-1308:42 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-003256
2020-01-1307:09 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-20-003216
2019-11-2616:30 ET8-K1.01 Entry into a material agreement0001104659-19-067634
2019-11-0611:55 ET10-QQuarterly reportPeriod 2019-09-300001558370-19-010099
2019-11-0607:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-060267
2019-10-0108:14 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001410578-19-001480
2019-09-3008:59 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001410578-19-001463
2019-08-2708:39 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001410578-19-000929
2019-08-0111:59 ET10-QQuarterly reportPeriod 2019-06-300001558370-19-006758
2019-08-0107:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-043177
2019-08-0107:22 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-043176
2019-07-2508:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-041727
2019-07-2208:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-041172
2019-07-1808:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-040874
2019-06-2708:08 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-037761
2019-05-1508:11 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-029550

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.